• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用能够漂浮在胃液上的聚碳酸酯微球的口服缓释药物递送系统。

Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid.

作者信息

Thanoo B C, Sunny M C, Jayakrishnan A

机构信息

Polymer Chemistry Division, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.

出版信息

J Pharm Pharmacol. 1993 Jan;45(1):21-4. doi: 10.1111/j.2042-7158.1993.tb03672.x.

DOI:10.1111/j.2042-7158.1993.tb03672.x
PMID:8094440
Abstract

Polycarbonate microspheres loaded with aspirin, griseofulvin and p-nitroaniline were prepared by a solvent evaporation technique. High drug loading (> 50%) was achieved by this process. Drug-loaded microspheres were found to float on simulated gastric fluid and intestinal fluid. Drug-release studies were carried out in these fluids at 37 degrees C. Increasing the drug to polymer ratio in the microspheres increased both their mean particle size and the release rate of the drugs. It was concluded that sustained delivery of drugs could be effected using this matrix.

摘要

采用溶剂蒸发技术制备了负载阿司匹林、灰黄霉素和对硝基苯胺的聚碳酸酯微球。通过该工艺实现了高载药量(>50%)。发现载药微球漂浮在模拟胃液和肠液上。在37℃下于这些液体中进行了药物释放研究。增加微球中药物与聚合物的比例会增加其平均粒径和药物释放速率。得出的结论是,使用这种基质可以实现药物的持续递送。

相似文献

1
Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid.使用能够漂浮在胃液上的聚碳酸酯微球的口服缓释药物递送系统。
J Pharm Pharmacol. 1993 Jan;45(1):21-4. doi: 10.1111/j.2042-7158.1993.tb03672.x.
2
Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.交联壳聚糖微球:作为药物控释基质的制备与评价
J Pharm Pharmacol. 1992 Apr;44(4):283-6. doi: 10.1111/j.2042-7158.1992.tb03607.x.
3
Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres.
J Pharm Pharmacol. 1993 Jan;45(1):16-20. doi: 10.1111/j.2042-7158.1993.tb03671.x.
4
A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits.基于中空聚碳酸酯微球的吡罗昔康漂浮型口服剂型:家兔体内外评价
J Control Release. 2002 Feb 19;79(1-3):71-9. doi: 10.1016/s0168-3659(01)00507-7.
5
Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.基于多孔载体的漂浮型奥利司他微球用于胃内给药的评价。
AAPS PharmSciTech. 2006 Nov 10;7(4):90. doi: 10.1208/pt070490.
6
Formation and in-vitro evaluation of theophylline-loaded poly(methyl methacrylate) microspheres.
J Pharm Pharmacol. 1988 Aug;40(8):530-3. doi: 10.1111/j.2042-7158.1988.tb05296.x.
7
Development and characterization of rifampicin loaded floating microspheres.利福平载药漂浮微球的研制与表征
Artif Cells Blood Substit Immobil Biotechnol. 2011 Oct;39(5):330-4. doi: 10.3109/10731199.2011.573482. Epub 2011 Jun 2.
8
Stomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheres.采用乙基纤维素漂浮微球实现 5-氟尿嘧啶的胃部靶向给药。
Pharm Dev Technol. 2010 Mar-Apr;15(2):154-61. doi: 10.3109/10837450903085392.
9
Preparation of Eudragit E100 microspheres by modified solvent evaporation method.采用改良溶剂蒸发法制备聚丙烯酸树脂E100微球。
Acta Pol Pharm. 2011 Nov-Dec;68(6):975-80.
10
Evaluation of an aliphatic polyurethane as a microsphere matrix for sustained theophylline delivery.评估一种脂肪族聚氨酯作为用于持续释放茶碱的微球基质。
J Microencapsul. 1995 Nov-Dec;12(6):617-25. doi: 10.3109/02652049509006792.

引用本文的文献

1
Cutting-Edge Developments and Patent Trends in Microspheres Drug Delivery: A Comprehensive Overview.微球药物递送的前沿发展与专利趋势:全面概述
Recent Pat Nanotechnol. 2025;19(3):434-452. doi: 10.2174/0118722105296316240626071243.
2
Synthesis of nanomedicine hydrogel microcapsules by droplet microfluidic process and their pH and temperature dependent release.通过微滴微流控技术合成纳米药物水凝胶微胶囊及其pH和温度依赖性释放
RSC Adv. 2021 Nov 23;11(60):37814-37823. doi: 10.1039/d1ra05207a.
3
To control floating drug delivery system in a simulated gastric environment by adjusting the Shell layer formulation.
通过调整壳层配方来控制模拟胃环境中的漂浮药物递送系统。
Biomater Res. 2021 Oct 9;25(1):31. doi: 10.1186/s40824-021-00234-6.
4
In-Depth Study into Polymeric Materials in Low-Density Gastroretentive Formulations.低密度胃滞留制剂中高分子材料的深入研究
Pharmaceutics. 2020 Jul 7;12(7):636. doi: 10.3390/pharmaceutics12070636.
5
Design and optimization of gastro-retentive microballoons for enhanced bioavailability of cinnarizine.用于提高桂利嗪生物利用度的胃滞留微球的设计与优化。
Drug Deliv Transl Res. 2016 Jun;6(3):210-24. doi: 10.1007/s13346-016-0280-4.
6
Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.新型载5-氟尿嘧啶胃靶向性位点特异性中空漂浮微球的研制与表征
ScientificWorldJournal. 2014;2014:705259. doi: 10.1155/2014/705259. Epub 2014 Oct 14.
7
Ketorolac tromethamine floating beads for oral application: Characterization and in vitro/in vivo evaluation.酮咯酸氨丁三醇口服漂浮珠:特性评价和体内外研究。
Saudi Pharm J. 2014 Sep;22(4):349-59. doi: 10.1016/j.jsps.2013.06.006. Epub 2013 Jul 12.
8
Gastroretentive microballoons of metformin: Formulation development and characterization.二甲双胍胃滞留微球:制剂开发与表征
J Adv Pharm Technol Res. 2011 Jan;2(1):51-5. doi: 10.4103/2231-4040.79806.
9
Development of theophylline floating microballoons using cellulose acetate butyrate and/or Eudragit RL 100 polymers with different permeability characteristics.使用具有不同渗透特性的醋酸丁酸纤维素和/或尤特奇RL 100聚合物制备茶碱漂浮微球。
Res Pharm Sci. 2010 Jan;5(1):29-39.
10
Ethyl cellulose microcapsules for protecting and controlled release of folic acid.乙基纤维素微胶囊,用于保护和控制叶酸的释放。
AAPS PharmSciTech. 2009;10(4):1104-12. doi: 10.1208/s12249-009-9305-3. Epub 2009 Sep 10.